Summary
Amgen Inc. (AMGN) filed an 8-K on April 21, 2015, to report its unaudited financial results for the first quarter ended March 31, 2015. The filing primarily references a press release (Exhibit 99.1) which details the company's operational and financial performance during the period. Investors should note that the press release includes both U.S. Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures, such as adjusted earnings per share and free cash flow. Amgen's management believes these non-GAAP measures offer valuable insights into the company's financial condition and operational results, providing a clearer picture of underlying performance by excluding certain items. Reconciliations between the GAAP and non-GAAP figures are provided within the press release. While this 8-K filing itself does not incorporate the press release content for the purposes of Section 18 of the Exchange Act, the press release contains the substantive information investors should review for quarterly performance analysis.
Key Highlights
- 1Amgen Inc. reported its first quarter 2015 financial results on April 21, 2015.
- 2The filing is primarily an announcement of earnings, referencing an attached press release (Exhibit 99.1) for detailed financial information.
- 3The press release includes both GAAP and non-GAAP financial measures.
- 4Key non-GAAP metrics highlighted include adjusted earnings per share and free cash flow.
- 5Management provided explanations for why non-GAAP measures are considered useful for investors.
- 6Reconciliations between GAAP and non-GAAP financial measures are available in the press release.
- 7The information in this 8-K is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.